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Abstract 
BACKGROUND: Today, the fractional flow reserve (FFR) guides the physician to select suitable 
patients with intermediate severity coronary lesions in angiography that should be treated or 
not with stent. The aim of this study was to evaluate the impact of using FFR in the selection of 
appropriate treatment strategy in angiographic intermediate coronary lesions and their short-
term outcome in a sample of Iranian population. 
METHODS: In a prospective cohort, 34 patients who had intermediate coronary artery lesion(s), 
defined as having a 40-70% diameter stenosis, as determined by visual estimation or 
quantitative coronary angiography were enrolled through a convenience sampling method. All 
patients underwent FFR measurement to decide whether percutaneous coronary intervention 
should be performed. The results of visual assessment, quantitative coronary angiography, and 
functional assessment of the severity of coronary stenosis were compared. Significant stenosis 
was defined as FFR < 0.80. All patients were followed for 6 months for the incidence of major 
advanced cardiac events. 
RESULTS: In this study, 34 patients (22 male and 12 female) with mean age of 57 ± 8 (range  
45-70) were included. In 26.47% (9/34) of patients, FFR was < 0.80, they underwent coronary 
angioplasty. The correlation between visual estimation and quantitative assessment of lesion 
diameter was 0.804 (P < 0.001). During the follow-up period, no major advanced cardiac events 
were reported. In addition, 5.88 (2/34) of patients had a left main (LM) lesion with FFR > 0.80 
and stenting was done to the other vessels with significant coronary lesions. 
CONCLUSION: Measurement of FFR is a useful approach in making clinical decisions about 
revascularization procedures in patients with moderate coronary artery lesion severity, 
especially in LM and multivessel disease. This study showed that not only FFR can change 
treatment plan of the patients, but also it would improve clinical outcomes. 
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Introduction 
Intermediate coronary artery lesions are defined as 
a diameter narrowing of ≥ 40% to ≤ 70%1 and is 
reported in about one third to half of coronary 
angiograms.2 The clinical significance and 
management strategy of these lesions are 
important.3 Visual estimation of coronary lesion 
severity in routine coronary angiography may be 
inaccurate because of two-dimensional views and 
inter/interobservervariability.3,4 Quantitative 
coronary angiograms are better suited, but they 
also have the same limitations in assessing 
coronary artery stenosis.1 In patients with angina 
pectoris and moderate coronary artery stenosis 
severity, as assessed by visual estimation in a 
coronary angiogram, decision making for the 
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selection of treatment strategies, stenting, or 
medical follow-up is a dilemma, and evaluation 
and treatment of lesions are challenging.3 In a 
considerable number of patients, coronary artery 
revascularization is performed without definite 
evidence that coronary stenosis is causing 
symptoms.5,6 In recent years, technical advances 
have provided new diagnostic devices to 
catheterization laboratories to evaluate the severity 
of coronary artery lesions. One of the diagnostic 
modalities for assessment of the functional 
importance of intermediate coronary lesion is 
fractional flow reserve (FFR), which is carried out 
by intracoronary pressure guide wires.7,8 Based on 
the pressure-flow analysis of coronary stenosis 
during maximal flow reserve,9 the concept of a 
myocardial FFR has been developed as an 
invasively determined index of the functional 
severity of coronary stenosis in intermediate 
lesion.10-13 FFR is defined as the ratio of maximum 
coronary blood flow in a stenotic area to 
maximum blood flow in the same vessel that is 
completely normal.10,14 In other words, FFR can be 
derived from the ratio of the mean distal coronary 
artery pressure (post stenotic-Pd) to the aortic 
pressure (Pa) during maximal hyperemia  
(FFR = Pd/Pa).10,15 This index is independent of 
changes in systemic blood pressure, heart rate, and 
left ventricular function, and it is unaffected by 
conditions known to increase the baseline 
myocardial flow.2,12 The normal value of the index 
is 1.0, regardless of the patient or the specific vessel 
studied.13 The FFR has been shown to correlate 
well with other noninvasive tests for the detection 
of ischemia.16-18 In contrast to most other invasive 
indexes, FFR has a direct clinical relevance.10,13,14,19 
For these reasons, FFR may be regarded as a gold 
standard for the evaluation of the physiological 
significance of intermediate coronary stenosis in 
catheterization laboratories, with extensive 
validation in randomized controlled trials.6 
We believe using FFR have been shown to 
improve patient outcomes in the short- and long-
term2,20,21 reduce the number of stents implanted by 
approximately 30% and are cost effective.21 
Therefore, without using these devices, stents 
(usually drug eluting stents) may be inserted in non-
significant lesions wrongly.3 
Our center (Chamran Heart Hospital, Isfahan, 
Iran) has been using intracoronary pressure guide 
wires since January 2013. Therefore, the purpose of 
this study was to describe our experiences with the 
use of this device. 
This study aimed to evaluate the impact of FFR 
in decision making for revascularization in patients 
with intermediate coronary stenosis and relevant 
angina in an Iranian population. It aimed to 
determine the complications associated with the use 
of FFR devices also. 
Materials and Methods 
The patient population consisted of 34 stable angina 
patients who consecutively underwent FFR 
assessment to decide whether to perform 
percutaneous coronary intervention (PCI) for de 
novo intermediate coronary lesions between January 
and December 2013. All cases were selected from 
patients who came to our center for coronary 
angiography as outpatients. An intermediate 
coronary artery lesion was defined as a 40-70% 
diameter1 stenosis through the visual estimation of 
two cardiologists separately. If their estimation was 
different, opinion of third cardiologist was 
considered as a final decision. A single operator 
blinded to clinical and FFR data performed an off-
line quantitative coronary angiogram on moderate 
coronary lesions to determine lesion length. For this 
study, the target vessel was a lesion in the proximal 
or mid part of a major epicardial coronary artery 
with a reference vessel diameter larger than 2.5 mm. 
Patients were excluded if they were in the setting of 
ST elevation of myocardial infarction for primary 
PCI; in the setting of acute coronary syndrome; had 
a major life-threatening illness; experienced 
contraindication to adenosine and anticoagulant or 
antiplatelet, or had prior coronary artery bypass 
surgery. Patients were eligible for enrollment if they 
had at least one intermediate lesion in their 
coronary artery tree. The cutoff value of FFR in the 
FFR-guided PCI group was 0.80.2,14,22 PCI was done 
if the FFR was > 80% and all implanted stents were 
commercially available third-generation drug-eluting 
stents. The patients gave us informed consent. 
Major advanced cardiac events defined as death, 
myocardial infarction, and ischemic driven target 
vessel revascularization (TVR) at 6 months follow-
up of all the patients were evaluated. During the 
follow-up period, all patients in the vascularized 
group received appropriate doses of Aspirin, 
metoprolol, an angiotensin-converting enzyme 
inhibitor, nitrate, and clopidogrel. 
Immediately after coronary angiography with 
standard technique,2 the coronary artery was 
selectively engaged with a 6F guiding catheter 
without side holes, and 200 µg nitroglycerin was 
administered intracoronary. A 0.014ʺ pressure guide 
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wire was calibrated at zero, advanced into the 
coronary artery, and positioned distal to the stenosis 
to be measured. FFR was determined during 
maximum hyperemia using the ratio Pd/Pa; Pd 
represents mean coronary pressure distal to the 
stenosis segment measured via the pressure wire, and 
Pa represents mean Pa measured via the guiding 
catheter. Maximum hyperemia was induced by 
intracoronary adenosine (≥ 30 µg in the right and 
 ≥ 40 µg in the left coronary artery).23 
All selected patients underwent coronary 
angiography by standard techniques via femoral 
approach. Coronary angiography was performed in 
multiple orthogonal views. Patients requiring FFR 
performance were chosen based on a visual 
estimation of coronary lesion severity by at least 
two cardiologists in each coronary artery. If patients 
were eligible for the study, informed consent was 
obtained. A single operator blinded to clinical and 
FFR data performed an off-line quantitative 
coronary angiogram on coronary moderate lesions. 
The most severe narrowing in no foreshortening 
view was used for quantitative coronary 
measurements (Siemens software, Siemens 
Healthcare GmbH, Germany); lesion length was 
obtained and recorded. 
All patients were followed for about 6 months, 
and the primary outcome was defined as a 
composite of major adverse cardiac event (MACE), 
defined as death, myocardial infarction, and 
ischemia-driven TVR at 12 months after the index 
procedure. Death was defined as all-cause mortality. 
The diagnosis of myocardial infarction was based 
on either the development of new pathological Q-
waves in two contiguous electrocardiogram leads 
and/or cardiac enzyme level elevation 3 times the 
upper limit of normal value. TVR included target 
lesion PCI and bypass surgery of the target lesion. 
TVR was performed only in the presence of 
symptoms and/or signs of ischemia3, so MACEs 
were recorded, if present. 
All values are expressed as mean ± standard 
deviation for continuous variables or as counts and 
percentages for categorical variables. All variables were 
compared using an appropriate statistical test. 
Kolmogorov-Smirnov test was used to evaluate if the 
distribution of data was normal. Pearson correlation 
coefficient tests were used for the correlation between 
quantitative variables and linear regression curves were 
drawn using the least square method. Independent t-
test was used to compare means of vessel diameter 
and a minimal luminal diameter between patients with 
FFR ≥ 0.80 and those with lower values. Statistical 
significance was assessed as P < 0.050 using a two-
tailed probability analysis. All data were analyzed SPSS 
software for Windows (version 20, SPSS Inc., 
Chicago, IL, USA). 
Results 
From the beginning of the January to 31 December 
2013, 10,000 angiography and interventional 
procedures were carried out in our center. Of these, 
34 patients (22 male and 12 female) with mean age 
57 ± 8 (range 45-70) who were undergoing clinically 
indicated coronary angiography and met inclusion 
criteria were enrolled in the study and underwent 
FFR assessment, pending informed consent from 
the patient and their physician. Clinical 
characteristic of all patients, including age, sex, 
ordinary atherosclerotic risk factors, and so on, 
were summarized in table 1. 
FFR measurements were done in 34 patients. 
There were no significant differences in reference 
vessel diameter and a minimal luminal diameter 
between patients with FFR ≥ 0.80 and those with 
lower values (P = 0.332 and P = 0.724, 
respectively). Angiography data, numbers of 
diseased vessels, type of involved vessel, lesion 
length, extent of stenosis, and FFR values are 
shown in table 1, as well. 
In 26.47% (9/34) of the patients, FFR was 
lower than 0.8 and they underwent coronary 
angioplasty and stenting with a drug-eluting stent. 
Two patients (5.88 %) had FFR above 0.80 in the 
intermediate lesion and stenting of the other 
vessel with significant lesions (stenosis > 70%) 
was done. For the other patients, the FFR was 
more than 80% and revascularization was not 
performed. In this study, three cases (8.82%) of 
left main (LM) with intermediate lesions were 
enrolled. If the FFR measurements showed no 
significant LM disease, revascularization protocol 
would change from urgent coronary bypass graft 
surgery to stenting of the other vessel with 
significant lesions. 
The correlation coefficient between FFR and 
lesion length and FFR and luminal stenosis  
was -0.599 (P < 0.001) and -0.430 (P = 0.011), 
respectively. The correlation between visual 
estimation of lesion diameter and quantitative 
measurement of lesion diameter was 0.804  
(P < 0.001). Visual estimation of lesion diameter 
and FFR showed a correlation of -0.576  
(P < 0.001), as shown in figure 1. 
During 6 months follow-up period no any 
MACEs were reported in both groups. 
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Table 1. Baseline characteristics of the patients (n = 34) 
Variables n (%) Mean ± SD 
Sex    
Female 12 (35.3) - 
Male 22 (64.7) - 
Age    
Female - 59.50 ± 10.30 
Male - 56.20 ± 8.40 
Total - 57.50 ± 9.20 
Risk factors    
DM 10 (29.4) - 
HTN 19 (55.9) - 
DLP 15 (44.1) - 
Smoking 14 (41.2) - 
FH 10 (29.4) - 
LVEF  - 51.76 ± 4.58 
Angina class   
I 10 (29.4) - 
II 18 (53.0) - 
III 5 (14.7) - 
IV 1 (2.9) - 
Angiography results    
Visual estimation - - 
Diameter stenosis - 59.60 ± 8.00 
QCA   
Reference diameter - 31.50 ± 0.49 
Diameter stenosis - 56.60 ± 7.80 
Lesion length - 15.00 ± 4.80 
FFR - 0.86 ± 0.09 
Treatment strategy    
PCI on target vessel 9 (26.5) - 
Medical 23 (67.6) - 
PCI on non-target 
vessel 2 (5.9) 
- 
Number of diseased vessels    
Single vessel 25 (83.5) - 
Two vessels 8 (23.5) - 
Three vessel 1 (2.9) - 
Type of diseased vessel    
LM 3 (8.8) - 
LAD 29 (25.3) - 
LCX 4 (11.8) - 
RCA 9 (26.5) - 
SD: Standard deviation; DM: Diabetes mellitus; HTN: 
Hypertension; DLP: Dyslipidemia; FH: Familial 
hypercholesterolemia; LVEF: Left ventricular ejection 
fraction; QCA: Quantitative coronary angiography; FFR: 
Fractional flow reserve; PCI: Percutaneous coronary 
intervention; LM: Left main; LAD: Left anterior descending; 
LCX: Left circumflex; RCA: Right coronary artery 
Significant complications did not occur during 
coronary adenosine administration, except for a 
transient severe bradycardia in nine patients and a 
transient complete heart blockage in one case. One 
lesion was not studied with pressure guide wires in 
the first attempt due to guide wire cross failure; the 
failed guide wire was then substituted with the next 
wire. Successful FFR measurements increased 
progressively after the early months of using 
pressure guide wires and increasing operator 
experience. The mean procedure time for the FFR 
measurement of a single lesion was 25 minutes  
(15-45), a period that included calibration, 
equalization, and hyperemia induction. This 
timeframe was not significantly different versus 
single vessel angioplasty, but in the cases of 
multivessel disease or vessels with multiple lesions, 
this was important. In the current study, 
misclassification of lesions with angiographic 
assessment alone amounted to more than 25%. 
Discussion 
This study demonstrated a new experience of an 
Iranian center in the use of pressure guide wires as a 
new technology for the assessment of intermediate 
coronary stenosis. 
Routine coronary angiography is not accurate in 
assessing the functional significance of coronary 
stenosis when compared with FFR, not only in the 
50-70% category, but also in the 70-90% category 
of angiographic severity.4 This is because of  
inter-/intra-observer variability that is about 27% 
and 15%, respectively, in this study. In our study all 
PCI was done by new third generation drug eluted 
stents, therefore, good outcomes and low MACEs 
in follow-up period may be for this reason, 
however, more participants are needed to evaluate 
this subject. A prominent physician from our center 
refused to use FFR measurements in the assessment 
of coronary lesion severity because of cost, time 
constraints, radiation exposure, and a higher 
likelihood of volume of contrast. This study, along 
with Leesar et al., showed that FFR procedures for 
measurement are safe, resulting in decreased 
radiation exposure, and no change in the amount of 
contrast in comparison to conditions with 
inappropriate stenting.24 
Despite the fact that myocardial single photon 
emission tomography (SPECT) has shown a high 
sensitivity of 90% or greater in the detection of 
multivessel coronary artery disease, accuracy is limited 
in the identification of each individual stenosis. 
Detection of reversible perfusion abnormalities, 
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especially of the culprit lesion, might fail in cases of a 
missing reference area, and the allocation of perfusion 
defects to target vessels is a well-known problem in 
these patients.25 In our study, some of the cases 
involved multivessel disease, so myocardial perfusion 
SPECT may not be useful for the functional 
assessment of intermediate lesions. Leesar et al. 
showed that the FFR significantly shortens the 
duration of hospitalization compared with stress 
perfusion scintigraphy.24 
Technical developments have made newer and 
better-designed tools available for coronary 
interventionist procedures. Sometimes, the 
complexity of devices, their cost, their limited field 
of application, or the scant yield of relevant 
information in an interventionist procedure mean 
that new devices are used only for research in few 
hemodynamic laboratories, or in sporadic cases with 
unusual presentation or evolution.26 In the present 
study, the FFR was used in < 0.5% of the 
interventionist procedures in our center, but it had a 
great negative impact on the need to do 
revascularization in the patient with intermediate 
lesions. It has an indication in about 30% of cases. 
Previous studies have shown that FFR above 0.75-
0.80 was a strong predictor of favorable clinical 
outcomes in patients with intermediate LM 
disease.27-31 
One of the major findings of the present study is 
the effect of FFR measurement in intermediate 
lesions of LM or proximal left anterior descending 
(LAD) or left circumflex (LCX). If FFR showed 
insignificant lesions in LM, proximal lesions of 
LAD or LCX can change the strategy for 
revascularization, [coronary artery bypass grafting 
(CABG) or stenting] medical treatment. This study 
showed that lesion length with a severity of lesion 
stenosis predicted lower FFR. Thus, FFR 
measurement is appropriate to identify patients with 
intermediate LM stenosis in whom deferral of 
revascularization may be associated with excellent 
outcomes.32 
 
 
 
Figure 1. Scatter plots and linear regression curves of fractional flow reserve versus visual and 
quantitative indices of coronary lesions 
FFR: Fractional flow reserve 
B A 
D 
C 
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In this study, from 35 patients coronary stenting 
was done in only 9 (26.5%) lesions that FFR 
showed significant stenosis, so this procedure 
prevented from inappropriate stenting of others 
(73.5%). The therapeutical decisions were changed 
from PCI or CABG in 23 patients (67.5%) to 
medical treatment. The treatment approach was 
changed from urgent CABG to Medical treatment 
or PCI on other lesions in three cases that had LM 
coronary artery lesions but without significant FFR 
findings. The current study with a low sample size 
showed that not only FFR can change treatment 
plan of the patients, but also it would improve 
clinical and economical outcomes by lowering 
inappropriate stenting.4 
Limitations  
The presence of small vessel disease, diffuse 
coronary artery disease, and left ventricular 
hypertrophy restrict the hyperemia induced by 
pharmacologic vasodilatation, so decreasing distal 
coronary pressure and the calculation of FFR 
measurements is limited.33 This study included a 
relatively small number of patients and a short 
course follow-up for event recording. 
Conclusion 
Measurement of FFR during coronary angiography is 
a useful method of assessing whether an intermediate 
coronary lesion based on a routine angiography is 
functionally significant and may be responsible for 
future cardiac events. Although this procedure is 
underused in catheterization laboratories, it is believed 
that FFR is a useful approach in clinical decision 
making about revascularization procedures in patients 
with moderate coronary artery lesion severity, 
especially in cases of LM and multivessel disease. This 
procedure had a significant negative effect in coronary 
revascularization in these patients. Therefore, this 
study is a good foundation for the increased use of 
functional assessments in our and other 
catheterization laboratories, and it should be a basis 
for new randomized trials. 
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